PRIMARY HYPOTHYREOSIS AND ITS CONSEQUENCES ON CARDIOVASCULAR SYSTEM

T. Novaković
T. Novaković

Internal clinic, Faculty of Medicine , Priština, Kosovska Mitrovica

Published: 01.01.2004.

Volume 32, Issue 1 (2004)

pp. 77-79;

https://doi.org/10.70949/pramed200401073N

Abstract

The thyroid gland produces two major active thyroid hormones, thyroxin (T4) and triiodothyronine (T3). The production of these hormones within the thyroid is regulated by thyreotropin (thyroid-stimulating-hormone- TSH). Iodine deficiency is the most common cause of goiter and borderline hypothireoidsm word-widw. In non iodine deficient areas, however autoimmunity is the most common cause of hypothyroidism. Destructive therapy by surgery or radioiodine for thyrotoxicosis acounts for approximately one third of all cases excessive iodine (e. g. as e result of chronic ingestion of proprietary cough medicines) may also cause hi pothyreoidsm. Primary hypothireoidsm due to failure much more common than failure secondary to pituitary dysfunction, or tertiary hypothireoidsm due to hypothalamic disease. The symptom of hypothireoidsm are non-specific and may be attributed by bath patient and doctor to ageing the onset usually being insidious. Hypothireoidsm is treated with replacement T4 therapy. The author describe a 55 year-old women with diagnosis of Primary hypothireoidism. The disease had a rarely course with disorders this metabolism lipids and complications here cardiovascular system. 

Keywords

References

1.
Trbojević B. Tiroidna žlezda: Primarni hipotireoidizam. 306-314. Zavod za udžbenike i nastavna sredstva.
2.
Wats GF. Cholesterol and Coronary Heart Disease: Discovering the Link.
3.
AM G, D P. Dyslipidemia and Atherosclerosis: A Forecast of Pharmaceutical Approaches. Circulation. 87:54–9.
4.
Kjekshuss J, Pedersen TR. For the Scandinavian Simvastatin Survival Study. Am J Cardiol. 76:64–8.
5.
Micić D. Hormonska supstituciona terapija u menopauzi i lipidi krvi. Bilten Odbora za lipide.
6.
Lalić N. Medikamentna terapija hiperlipoproteinemija u lečenju i prevenciji ateroskleroze. Bilten Jugoslovenskog udruženja za borbu protiv ateroskleroze. Broj. 2:6–12.
7.
Tikkanen MJ, Lewis B. Use of the HMG-CoA reductase inhibitors in clinical practice. Lipid Rev.
8.
Lepšanović L, Lj L. Klinička lipidologija: Lipidi i ateroskleroza.
9.
Brown MS, Goldstein JL. The Hyperlipoproteinemias and Other Disorders of Lipid Metabolism. In: Harrison’s Principles of Internal Medicine. p. 1650–63.
10.
Manojlović D. Lipidi i endotel. Medicinski.
11.
Henkin Y, Como AJ, Oerman A. Secundary Dyslipidemia: Inadvertent Effects.
12.
Đurica S, Davidović M, Milošević P. Štitasta žlezda i starenje.
13.
Miller WP, Elite J. Atheromatosis and Coronary Artery Disease.
14.
Slijepčević S, Vujović S, Nestrović Z. Humana klinička endokrinologija.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by